Search Results - "Kabanov, S. N."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    A Device for Determining the Optimum Graft Length in Reconstructive Microsurgery by Maslyakov, V. V., Baranov, N. A., Kabanov, S. N.

    Published in Biomedical engineering (01-11-2018)
    “…In this work, the principle of operation of a device for determination of the optimum length of grafts used in reconstructive surgery of damaged tendons,…”
    Get full text
    Journal Article
  2. 2

    Epoetin alpha in the treatment of anemia in patients with malignant solid tumors during antitumor drug therapy by Vladimirova, L. Yu, Abramova, N. A., Lyanova, A. A., Storozhakova, A. E., Popova, I. L., Teplyakova, M. A., Tikhanovskaya, N. M., Ryadinskaya, L. A., Kalabanova, E. A., Kabanov, S. N., Udalenkova, I. A.

    Published in Medicinskij sovet (19-06-2022)
    “…Introduction . Erythropoietin (EPO) application is a pathogenetic method for anemia correction in cancer patients. The purpose of study . Clinical evaluation…”
    Get full text
    Journal Article
  3. 3

    Formation and structural phase transition in Co atomic chains on a Cu(775) surface by Syromyatnikov, A. G., Kabanov, N. S., Saletsky, A. M., Klavsyuk, A. L.

    “…The formation of Co atomic chains on a Cu(775) surface is investigated by the kinetic Monte Carlo method. It is found that the length of Co atomic chains…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Checkpoint inhibitors in non-small cell lung carcinoma therapy for progression to the brain (clinical observation) by Vladimirova, L. Yu, Popova, I. L., Abramova, N. A., Teplyakova, M. A., Tikhanovskaya, N. M., Lianova, A. A., Storozhakova, A. E., Ryadinskaya, L. A., Kabanov, S. N., Kalabanova, E. A.

    Published in Medicinskij sovet (19-06-2022)
    “…The development of a new area of antitumor drug therapy, immunotherapy using immune checkpoint inhibitors targeting PD-1/PD-L1, has significantly changed…”
    Get full text
    Journal Article
  6. 6

    Experience of pemetrexed in maintenance therapy for metastatic lung adenocarcinoma by Vladimirova, L. Yu, Storozhakova, A. E., Kalabanova, E. A., Meshcheryakov, P. N., Oskin, S. V., Kabanov, S. N., Samaneva, N. Yu, Svetitskaya, Ya. V., Tishina, A. V.

    “…Lung cancer is among the most common malignant diseases in Russia. In 80–90%, its morphological type is nonsmall cell lung cancer. Stage IV primary advanced…”
    Get full text
    Journal Article
  7. 7

    Bevacizumab in maintenance therapy for ovarian cancer patients by Vladimirova, L. Yu, Storozhakova, A. E., Kalabanova, E. A., Verenikina, E. V., Kabanov, S. N., Svetitskaya, Ya. V., Samaneva, N. Yu, Tikhanovskaya, N. M., Novoselova, K. A., Selezneva, O. G., Tishina, A. V.

    “…Ovarian cancer is one of the most common cancers in women. Growth and extension of the tumor are associated with active neoangiogenesis regulated by vascular…”
    Get full text
    Journal Article
  8. 8

    Some aspects of nivolumab administration in treatment for metastatic melanoma (clinical cases) by Vladimirova, L. Yu, Storozhakova, A. Eh, Popova, I. L., Kabanov, S. N., Abramova, N. A., Teplyakova, M. A., Tikhanovskaya, N. M., Novoselova, K. A., Lyanova, A. A., Ryadinskaya, L. A., Myagkova, V. S., Alieva, F. V., Kalabanova, E. A., Svetitskaya, Ya. V., Samaneva, N. Yu, Tishina, A. V.

    Published in Medicinskij sovet (07-08-2021)
    “…The development of a new direction in anticancer medical therapy – the use of immune checkpoint inhibitors targeting PD-1/ PD-L1 and CTLA-4 – has significantly…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Study of polymorphisms of UGT1A1 and DPYD genes in chemotherapy for colorectal cancer by Timoshkina, N. N., Bogomolova, O. A., Zhuzhelenko, I. A., Kabanov, S. N., Kalabanova, E. A., Mitashok, I. S., Svetitskaya, Ya. V., Vodolazhskii, D. I.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (01-01-2019)
    “…Background. The personalized approach implies an individual choice of medicines and their doses for the patient, providing the most effective and safe…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Blood levels of growth and progression factors in patients with locally advanced breast cancer during neoadjuvant chemotherapy by E. M. Frantsiyants, N. Yu. Samaneva, L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, S. N. Kabanov, A. V. Tishina

    “…Purpose of the study. An analysis of blood levels of TGF-β, TGFR2, TNF-α, TNF-αR1, TNF-αR2, CD44 and MMP9 in patients with various biological subtypes of…”
    Get full text
    Journal Article
  14. 14

    Bandgap opening in hydrogenated germanene by Yao, Q., Zhang, L., Kabanov, N. S., Rudenko, A. N., Arjmand, T., Rahimpour Soleimani, H., Klavsyuk, A. L., Zandvliet, H. J. W.

    Published in Applied physics letters (23-04-2018)
    “…We have studied the hydrogenation of germanene synthesized on Ge2Pt crystals using scanning tunneling microscopy and spectroscopy. The germanene honeycomb…”
    Get full text
    Journal Article
  15. 15

    Atomic structure of self-organizing iridium induced nanowires on Ge(001) by Kabanov, N.S., Heimbuch, R., Zandvliet, H.J.W., Saletsky, A.M., Klavsyuk, A.L.

    Published in Applied surface science (15-05-2017)
    “…•Ir/Ge(001) structure has been studied with DFT calculations and scanning tunneling microscopy.•Ir/Ge(001) nanowires are composed of Ge atoms and Ir atoms are…”
    Get full text
    Journal Article
  16. 16

    The Au modified Ge(1 1 0) surface by Zhang, L., Kabanov, N.S., Bampoulis, P., Saletsky, A.M., Zandvliet, H.J.W., Klavsyuk, A.L.

    Published in Applied surface science (01-05-2018)
    “…•The structure of the β phase of Au-induced nanowires on Ge(1 1 0) system is studied with DFT calculations and STM.•The structure of the β phase is composed of…”
    Get full text
    Journal Article
  17. 17

    Results of treatment of patients with locally advanced and metastatic non-squamous cell non-small-cell lung carcinoma with pemetrexed (by own experience) by Vladimirova, L.Yu, Storozhakova, A.E., Kabanov, S.N., Kalabanova, E.A.

    Published in Sibirskiĭ onkologicheskiĭ zhurnal (01-04-2016)
    “…Lung cancer is one of the most common malignant tumors. As over 70 % of patients at diagnosis have locally advanced or generalized process, the majority of…”
    Get full text
    Journal Article
  18. 18

    Experience with the use of palonosetron (onicit) in patients with solid tumors receiving cytostatic therapy by Vladimirova, L Yu, Mitashok, I S, Storozhakova, A E, Kalabanova, E A, Svetitskaya, Ya V, Kabanov, S N

    Published in Voprosy onkologij (2015)
    “…Nausea and vomiting are among adverse effects of chemotherapy that significantly worsen quality of life of patients. 5-HT3 receptor antagonists have been used…”
    Get more information
    Journal Article
  19. 19